ArticleImmunotherapy advances2022
TIM-3: a tumor-associated antigen beyond checkpoint inhibition?
Stefan Barth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleImmunotherapy advances2022
Stefan Barth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.